Acorda Therapeutics (ACOR) to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
11/16/2009 8:49:03 AM
More...
|
Acorda Therapeutics (ACOR) Reports Third Quarter 2009 Financial Results
11/3/2009 8:54:50 AM
More...
|
Acorda Therapeutics (ACOR) to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009
10/27/2009 10:01:43 AM
More...
|
Acorda Therapeutics (ACOR) (JOBS) Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010
10/22/2009 6:49:33 AM
More...
|
Acorda Therapeutics (ACOR) (JOBS) Announces Positive Vote by FDA Advisory Committee for Fampridine-SR
10/15/2009 6:52:49 AM
More...
|
Acorda Therapeutics (ACOR) (JOBS) Stock Trading Halted Today; FDA Advisory Committee to Review Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
10/14/2009 7:34:33 AM
More...
|
US FDA Staff Says Limited Effect with Acorda Therapeutics (ACOR) (JOBS) MS Drug
10/9/2009 6:58:53 AM
More...
|
Acorda Therapeutics (ACOR) Announces Data on Retention Rates and Safety from Two Phase 3 Fampridine-SR Extension Studies
9/15/2009 9:40:23 AM
More...
|
Acorda Therapeutics (ACOR) Announces Interim Analysis of Two-Year Efficacy and Safety Data from Phase 3 Fampridine-SR Extension Study
9/10/2009 10:16:34 AM
More...
|
Acorda Therapeutics (ACOR) Reports Date of FDA Advisory Committee Review of Fampridine-SR for Improvement of Walking Ability in People with MS
8/25/2009 8:32:49 AM
More...
|
|